Stanley J. Robboy
Professor Emeritus of PathologyOverview
My research program, largely histopathological, concerns definitions of criteria, biological properties, differential diagnosis, and survival associated with pathological lesions in the female genital tract. With the gynecologic oncologists at Duke, we have reviewed the Institution's long term experience of endometrial cancer and with the International Collaborative Group on Endometrium, we have developed a new classification system for endometrial hyperplasia that better differentiates precancerous from benign lesions. In a nationwide NIH study in which I head the pathology review, long term complications in both sons and daughters from prenatal exposure to DES are being assessed. A major initiative is a study of vulvar dermatoses and unusual vulvar neoplasms. A final clinical pathologic correlation study, ongoing for over 40 years, has been the long term follow-up of a very rare tumor (malignant struma ovarii). Long term study has been required to identify those features that will ultimately prove to be of biologic significance for defining cases which will likely recur.
Positions
Professor Emeritus of Pathology in the School of Medicine
2022 School of Medicine
Vice-Chair for Diagnostic Pathology in the Department of Pathology in the School of Medicine
1998 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
1992 School of Medicine
Education
M.D. 1965
1965 University of Michigan, Ann Arbor
Intern, Pathology
1966 Icahn School of Medicine at Mount Sinai
Chief Resident, Pathology
1970 Massachusetts General Hospital
Publications, Grants & Awards
Offices & Contact
Durham, NC
27710 Duke Box 3712
Durham, NC
27710